When combined with diet and exercise, semaglutide may promote weightloss and decrease the risk of cancer, diabetes and cardiovascular disease in individuals with obesity or overweight.
With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans ...
Some results have been hidden because they may be inaccessible to you